Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients.
We report on the long-term clinical course of 4 boys with Menkes disease, treated from early infancy with parenteral copper-histidine, with follow-up over 10-20 years. Three of the 4 had male relatives with a severe clinical course compatible with classical Menkes disease. As a consequence of early treatment, our patients have normal or near-normal intellectual development, but have developed many of the more severe somatic abnormalities of the related disorder, occipital horn syndrome, including severe orthostatic hypotension in 2. In addition, 1 boy developed a previously unreported anomaly, namely, massive splenomegaly and hypersplenism as a consequence of a splenic artery aneurysm. Previously reported molecular studies in 2 of these patients had shown gene defects which would have predicted a truncated and probably nonfunctional gene product. Despite the favorable effects on the neurological symptoms, parenteral copper treatment for Menkes disease should still be regarded as experimental. The development of more effective treatments must await a more precise delineation of the role which the Menkes protein plays in intracellular copper trafficking.
Christodoulou
J
J
Division of Clinical Genetics, Hospital for Sick Children, Toronto, Ontario, Canada.
Danks
D M
DM
Sarkar
B
B
Baerlocher
K E
KE
Casey
R
R
Horn
N
N
Tümer
Z
Z
Clarke
J T
JT
D000293:Adolescent; D000328:Adult; D002648:Child; D003300:Copper / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006639:Histidine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D007706:Menkes Kinky Hair Syndrome / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography
D006639:Histidine; D003300:Copper